BD Neoflon IV cannula - risk of delay in treatment

(Becton Dickinson) Due to increased risk of the catheter buckling during initial puncture of skin. (MDA/2013/074)

CAS deadlines

Action underway: 24 October 2013, action complete: 7 November 2013

Note: These deadlines are for staff to be aware of the potential problem.


BD Neoflon™ IV cannula

Manufactured by Becton Dickinson

All lots of:

  • Product code: 391350, size: 24 G, NHSSC code: FSP070
  • Product code: 391349, size: 26 G.

This is a disposable device designed to gain access to peripheral veins of the patient’s blood system for rehydration, parenteral nutrition, medication delivery, blood transfusion and monitoring purposes.  This device is intended for use on neonatal, paediatric and geriatric patients.


Risk of delay in treatment due to increased risk of the catheter buckling during initial puncture of skin.

Due to a change in manufacturing process, the manufacturer has become aware of an increase in reported incidents of the catheter buckling in use.

Becton Dickinson does not currently have stock available to replace affected devices.

New product is being manufactured and should be available for supply from the beginning of October.

Becton Dickinson has not issued a Field Safety Notice in relation to this issue.


  • Ensure staff are aware of this potential problem.
  • Exercise additional care and vigilance when using this product and, if possible, use alternative devices until new product is available from Becton Dickinson.
  • Report any incidents of devices buckling to the MHRA.

Action by

All healthcare workers who use these devices and personnel involved in the purchase, supply and distribution of these devices.


This MDA has been sent to:

  • Care Quality Commission (CQC) (headquarters) for information
  • Clinical commissioning groups (CCGs)
  • HSC trusts in Northern Ireland (chief executives)
  • Local authorities in Scotland (equipment coordinators)
  • NHS boards and trusts in Wales (chief executives)
  • NHS boards in Scotland (equipment coordinators)
  • NHS England area teams
  • NHS trusts in England (chief executives)

Onward distribution

Please bring this notice to the attention of relevant employees in your establishment. 
Below is a suggested list of recipients.

CAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:

  • All departments
  • All staff
  • All wards
  • Ambulance services directors
  • Ambulance staff
  • Clinical governance leads
  • Community children’s nurses
  • Community hospitals
  • Community nurses
  • District nurses
  • Health and safety managers
  • Hospital at home units
  • IV nurse specialists
  • Medical directors
  • Neonatal nurse specialists
  • NHS walk-in centres
  • Nursing executive directors
  • Outpatient clinics
  • Outpatient theatre nurses
  • Paediatric nurse specialists
  • Paediatricians
  • Paediatrics departments
  • Palliative care teams
  • Paramedics
  • Purchasing managers
  • Resuscitation officers and trainers
  • Risk managers
  • Special care baby units
  • Supplies managers
  • Theatre managers
  • Theatre nurses
  • Theatres
  • Walk-in centres

NHS England area teams 
CAS liaison officers for onward distribution to all relevant staff including:

  • Nutritional nurse specialists

Independent distribution

Establishments registered with the Care Quality Commission (CQC) (England only)
This alert should be read by:

  • Adult placement
  • Care homes providing nursing care (adults)
  • Care homes providing personal care (adults)
  • Clinics
  • Domiciliary care providers
  • Hospices
  • Hospitals in the independent sector
  • Independent treatment centres
  • Nursing agencies
  • Private medical practitioners

Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health’s Central Alerting System (CAS) by sending an email to: and requesting this facility.

Manufacturer contact

BD Medical UK Ltd
The Danby Building
Edmund Halley Road
Oxford Science Park

General enquiries 01865 781 517



If you have any comments or feedback on this Medical Device Alert please email us at:


If you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2013/074 or 2013/001/016/401/005.

Technical aspects

Louise Mulroy and Ainsley Wickens
Medicines & Healthcare Products Regulatory Agency
Floor 4, 151 Buckingham Palace Road
London SW1W 9SZ

Tel:    020 3080 7344 and 7273
Fax:     020 8754 3965


Clinical aspects

Mark Grumbridge
Medicines & Healthcare Products Regulatory Agency
Floor 4, 151 Buckingham Palace Road
London SW1W 9SZ

Tel:    020 3080 7128
Fax:     020 8754 3965


How to report adverse incidents

Please report via our website: Reporting adverse incidents involving medical devices
Further information about CAS can be found on the CAS website 

Northern Ireland

Alerts in Northern Ireland will continue to be distributed via the NI SABS system.

Enquiries and adverse incident reports in Northern Ireland should be addressed to:

Northern Ireland Adverse Incident Centre
Health Estates Investment Group
Room 17
Annex 6
Castle Buildings
Stormont Estate
Dundonald BT4 3SQ

Tel: 02890 523 704
Fax: 02890 523 900


How to report adverse incidents in Northern Ireland

Please report directly to NIAIC, further information can be found on the NIAIC website
Further information about SABS can be found on the SABS website


Enquiries and adverse incident reports in Scotland should be addressed to:

Incident Reporting and Investigation Centre
NHS National Services Scotland
Gyle Square
1 South Gyle Crescent
Edinburgh EH12 9EB

Tel: 0131 275 7575
Fax: 0131 314 0722



Enquiries in Wales should be addressed to:

Improving Patient Safety Team
Medical Directorate
Welsh Government
Cathays Park
Cardiff CF10 3NQ

Tel: 029 2082 3922


Download documents

Medical Device Alert: BD NeoflonTM IV cannula manufactured by Becton Dickinson (MDA/2013/074) (75Kb)

Help us improve GOV.UK

Don’t include personal or financial information, eg your National Insurance number or credit card details.